obesity drug news today october 2025 glp-1 2024 was a record year for trials and is already poised to take over obesity drug news today glp-1

Bone microstructure High-resolution peripheral quantitative computed tomography (HR-pQCT) revealed declines in vBMD at both the radius and tibia, with particularly pronounced reductions in total and cortical vBMD at the tibia in postmenopausal women

The slow dissociation rate and significant receptor affinity prolong the pharmacological effect [233], [234]

The retatrutide dosage schedule after high-dose tirzepatide covers this scenario in detail

A comprehensive literature search was performed using electronic databases including PubMed, Scopus, and Google Scholar

The platform is committed to providing high-quality in vivo pharmacology research services to accelerate the development of novel therapies for liver diseases